Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

134 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Challenging Endocrine Sensitivity of Hormone Receptor-Positive/HER2-Negative Advanced Breast Cancer with the Combination of Eribulin and Endocrine Therapy: The REVERT Study.
López González A, Del Barco Berrón S, Grau I, Galan M, Castelo Fernández B, Cortés A, Sánchez Rovira P, Martinez-Bueno A, Gonzalez X, García A, Gener P, Mina L, Alcalá-López D, Sampayo M, Cortés J, Pérez-Garcia JM, Llombart-Cussac A, López-Miranda E. López González A, et al. Cancers (Basel). 2022 Nov 29;14(23):5880. doi: 10.3390/cancers14235880. Cancers (Basel). 2022. PMID: 36497361 Free PMC article.
A roadmap for accelerated drug approval in breast cancer?
Perez-Garcia J, Cortes J. Perez-Garcia J, et al. Lancet Oncol. 2012 Sep;13(9):850-1. doi: 10.1016/S1470-2045(12)70367-4. Epub 2012 Aug 9. Lancet Oncol. 2012. PMID: 22884504 No abstract available.
Therapeutic antibodies in breast cancer.
Pérez-Garcia J, Muñoz-Couselo E, Cortés J, Scaltriti M. Pérez-Garcia J, et al. Semin Oncol. 2014 Oct;41(5):576-88. doi: 10.1053/j.seminoncol.2014.07.002. Epub 2014 Jul 21. Semin Oncol. 2014. PMID: 25440604 Review.
134 results